Kanya Rajangam - Net Worth and Insider Trading
Kanya Rajangam Net Worth
The estimated net worth of Kanya Rajangam is at least $0 dollars as of 2024-11-05. Kanya Rajangam is the Chief Medical Officer of Nkarta Inc and owns about 0 shares of Nkarta Inc (NKTX) stock worth over $0. Details can be seen in Kanya Rajangam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kanya Rajangam has not made any transactions after 2021-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kanya Rajangam
Kanya Rajangam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kanya Rajangam owns 3 companies in total, including Nkarta Inc (NKTX) , Senti Biosciences Inc (SNTI) , and Turnstone Biologics Corp (TSBX) .
Click here to see the complete history of Kanya Rajangam’s form 4 insider trades.
Insider Ownership Summary of Kanya Rajangam
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTX | Nkarta Inc | 2021-08-05 | Chief Medical Officer |
| SNTI | Senti Biosciences Inc | 2022-07-05 | Chief Medical & Devt. Officer |
| TSBX | Turnstone Biologics Corp | 2023-07-20 | director |
Kanya Rajangam Latest Holdings Summary
Kanya Rajangam currently owns a total of 1 stock. Kanya Rajangam owns 0 shares of Nkarta Inc (NKTX) as of August 5, 2021, with a value of $0.
Latest Holdings of Kanya Rajangam
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTX | Nkarta Inc | 2021-08-05 | 0 | 3.26 | 0 |
Holding Weightings of Kanya Rajangam
Kanya Rajangam Form 4 Trading Tracker
According to the SEC Form 4 filings, Kanya Rajangam has made a total of 1 transactions in Nkarta Inc (NKTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nkarta Inc is the sale of 10,000 shares on August 5, 2021, which brought Kanya Rajangam around $372,800.
Insider Trading History of Kanya Rajangam
- 1
Kanya Rajangam Trading Performance
Kanya Rajangam Ownership Network
Ownership Network List of Kanya Rajangam
Ownership Network Relation of Kanya Rajangam
Kanya Rajangam Owned Company Details
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Kanya Rajangam is the Chief Medical Officer of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Kanya Rajangam made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .
In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
Kanya Rajangam Mailing Address
Above is the net worth, insider trading, and ownership report for Kanya Rajangam. You might contact Kanya Rajangam via mailing address: C/o Senti Biosciences, Inc., 2 Corporate Drive, First Floor, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
